000 01075 a2200265 4500
005 20250517032321.0
264 0 _c20160808
008 201608s 0 0 eng d
022 _a1874-4702
024 7 _a10.2174/1874467208666150507093258
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSoldatov, Nikolai M
245 0 0 _aCACNB2: An Emerging Pharmacological Target for Hypertension, Heart Failure, Arrhythmia and Mental Disorders.
_h[electronic resource]
260 _bCurrent molecular pharmacology
_c2015
300 _a32-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Intramural
650 0 4 _aArrhythmias, Cardiac
_xdrug therapy
650 0 4 _aCalcium Channels, L-Type
_xdrug effects
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aMental Disorders
_xdrug therapy
773 0 _tCurrent molecular pharmacology
_gvol. 8
_gno. 1
_gp. 32-42
856 4 0 _uhttps://doi.org/10.2174/1874467208666150507093258
_zAvailable from publisher's website
999 _c24893447
_d24893447